SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-020902
Filing Date
2021-04-27
Accepted
2021-04-27 16:19:12
Documents
68
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q crsp-10q_20210331.htm   iXBRL 10-Q 1913170
2 EX-10.1 crsp-ex101_13.htm EX-10.1 770740
3 EX-10.2 crsp-ex102_12.htm EX-10.2 39087
4 EX-10.3 crsp-ex103_11.htm EX-10.3 54407
5 EX-10.4 crsp-ex104_533.htm EX-10.4 1116701
6 EX-31.1 crsp-ex311_8.htm EX-31.1 19302
7 EX-31.2 crsp-ex312_7.htm EX-31.2 19506
8 EX-32.1 crsp-ex321_6.htm EX-32.1 8227
  Complete submission text file 0001564590-21-020902.txt   10297564

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA crsp-20210331.xsd EX-101.SCH 55919
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE crsp-20210331_cal.xml EX-101.CAL 52030
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE crsp-20210331_def.xml EX-101.DEF 174494
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE crsp-20210331_lab.xml EX-101.LAB 422589
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE crsp-20210331_pre.xml EX-101.PRE 304004
14 EXTRACTED XBRL INSTANCE DOCUMENT crsp-10q_20210331_htm.xml XML 1748823
Mailing Address BAARERSTRASSE 14 ZUG V8 CH-6300
Business Address BAARERSTRASSE 14 ZUG V8 CH-6300 6173154600
CRISPR Therapeutics AG (Filer) CIK: 0001674416 (see all company filings)

IRS No.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37923 | Film No.: 21859182
SIC: 2836 Biological Products, (No Diagnostic Substances)